Advertisement
Screener

LivaNova PLC (LIVN) Interest Expense

2.8 / 5 stars · 68/120 Roast Me

LivaNova PLC Interest Expense

LivaNova PLC (LIVN) reported Interest Expense of $15.89 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-03.

Discontinued › Expense Statement

us-gaap:InterestExpense · last filed 2024-05-03

  • LivaNova PLC interest expense for the quarter ending 2024-03-31 was $15.89M, a 18.28% increase year-over-year.
  • LivaNova PLC interest expense for the quarter ending 2023-12-31 was $15.62M, a 16.91% increase year-over-year.
  • LivaNova PLC interest expense for the quarter ending 2023-09-30 was $14.99M, a 18.36% increase year-over-year.
  • LivaNova PLC interest expense for the quarter ending 2023-06-30 was $14.81M, a 2.93% increase year-over-year.
  • LivaNova PLC interest expense for fiscal 2023 was $58.85M, a 21.98% increase from fiscal 2022.
  • LivaNova PLC interest expense for fiscal 2022 was $48.25M, a 3.79% decline from fiscal 2021.
  • LivaNova PLC interest expense for fiscal 2021 was $50.15M, a 22.81% increase from fiscal 2020.
  • LivaNova PLC interest expense for fiscal 2020 was $40.84M, a 170.60% increase from fiscal 2019.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 8 monthInterest Expense 9 monthInterest Expense 12 month
2024-03-31$15.89M
10-Q · filed 2024-05-03
$31.51M
derived: sum of 2 quarters · filed 2024-05-03
$46.50M
derived: sum of 3 quarters · filed 2024-05-03
$61.31M
derived: sum of 4 quarters · filed 2024-05-03
2023-12-31$15.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$30.61M
derived: sum of 2 quarters · filed 2024-02-29
$45.42M
derived: sum of 3 quarters · filed 2024-02-29
$58.85M
10-K · filed 2024-02-29
2023-09-30$14.99M
10-Q · filed 2023-11-01
$29.80M
derived: sum of 2 quarters · filed 2023-11-01
$43.23M
10-Q · filed 2023-11-01
$56.59M
derived: sum of 4 quarters · filed 2024-05-03
2023-06-30$14.81M
10-Q · filed 2023-07-26
$28.25M
10-Q · filed 2023-07-26
$41.61M
derived: sum of 3 quarters · filed 2024-05-03
$54.27M
derived: sum of 4 quarters · filed 2024-05-03
2023-03-31$13.44M
10-Q · filed 2024-05-03
$26.80M
derived: sum of 2 quarters · filed 2024-05-03
$39.46M
derived: sum of 3 quarters · filed 2024-05-03
$53.85M
derived: sum of 4 quarters · filed 2024-05-03
2022-12-31$13.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$26.02M
derived: sum of 2 quarters · filed 2024-02-29
$40.41M
derived: sum of 3 quarters · filed 2024-02-29
$48.25M
10-K · filed 2024-02-29
2022-09-30$12.66M
10-Q · filed 2023-11-01
$27.05M
derived: sum of 2 quarters · filed 2023-11-01
$34.89M
10-Q · filed 2023-11-01
$41.23M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$14.39M
10-Q · filed 2023-07-26
$22.23M
10-Q · filed 2023-07-26
$28.57M
derived: sum of 3 quarters · filed 2024-02-29
$39.93M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$7.84M
10-Q · filed 2023-05-03
$14.19M
derived: sum of 2 quarters · filed 2024-02-29
$25.54M
derived: sum of 3 quarters · filed 2024-02-29
$42.05M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$6.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$17.70M
derived: sum of 2 quarters · filed 2024-02-29
$34.22M
derived: sum of 3 quarters · filed 2024-02-29
$50.15M
10-K · filed 2024-02-29
2021-09-30$11.36M
10-Q · filed 2022-11-02
$27.87M
derived: sum of 2 quarters · filed 2022-11-02
$43.81M
10-Q · filed 2022-11-02
$59.41M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$16.52M
10-Q · filed 2022-08-03
$32.45M
10-Q · filed 2022-08-03
$48.05M
derived: sum of 3 quarters · filed 2023-02-27
$62.72M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$15.94M
10-Q · filed 2022-05-04
$31.54M
derived: sum of 2 quarters · filed 2023-02-27
$46.21M
derived: sum of 3 quarters · filed 2023-02-27
$51.92M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$15.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$30.27M
derived: sum of 2 quarters · filed 2023-02-27
$35.99M
derived: sum of 3 quarters · filed 2023-02-27
$40.84M
10-K · filed 2023-02-27
2020-09-30$14.67M
10-Q · filed 2021-11-03
$20.39M
derived: sum of 2 quarters · filed 2021-11-03
$25.24M
10-Q · filed 2021-11-03
$29.84M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$5.71M
10-Q · filed 2021-07-28
$10.56M
10-Q · filed 2021-07-28
$15.16M
derived: sum of 3 quarters · filed 2022-03-01
$19.94M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$4.85M
10-Q · filed 2021-04-28
$9.45M
derived: sum of 2 quarters · filed 2022-03-01
$14.22M
derived: sum of 3 quarters · filed 2022-03-01
$18.28M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$4.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$9.38M
derived: sum of 2 quarters · filed 2022-03-01
$13.43M
derived: sum of 3 quarters · filed 2022-03-01
$15.09M
10-K · filed 2022-03-01
2019-09-30$4.77M
10-Q · filed 2020-10-29
$8.83M
derived: sum of 2 quarters · filed 2020-10-29
$10.49M
10-Q · filed 2020-10-29
$12.56M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$4.05M
10-Q · filed 2020-07-29
$5.72M
10-Q · filed 2020-07-29
$7.79M
derived: sum of 3 quarters · filed 2021-03-01
$10.42M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$1.66M
10-Q · filed 2020-04-30
$3.74M
derived: sum of 2 quarters · filed 2021-03-01
$6.37M
derived: sum of 3 quarters · filed 2021-03-01
$9.38M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$2.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$4.71M
derived: sum of 2 quarters · filed 2021-03-01
$7.71M
derived: sum of 3 quarters · filed 2021-03-01
$9.82M
10-K · filed 2021-03-01
2018-09-30$2.63M
10-Q · filed 2019-10-30
$5.64M
derived: sum of 2 quarters · filed 2019-10-30
$7.75M
10-Q · filed 2019-10-30
$10.23M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$3.01M
10-Q · filed 2019-07-31
$5.12M
10-Q · filed 2019-07-31
$7.60M
derived: sum of 3 quarters · filed 2020-03-02
$9.02M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$2.11M
10-Q · filed 2019-05-01
$4.59M
derived: sum of 2 quarters · filed 2020-03-02
$6.01M
derived: sum of 3 quarters · filed 2020-03-02
$7.59M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$2.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$3.90M
derived: sum of 2 quarters · filed 2020-03-02
$5.48M
derived: sum of 3 quarters · filed 2020-03-02
$7.80M
10-K · filed 2020-03-02
2017-09-30$1.42M
10-Q · filed 2018-11-01
$3.00M
derived: sum of 2 quarters · filed 2018-11-01
$5.31M
10-Q · filed 2018-11-01
$9.27M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30$1.58M
10-Q · filed 2018-08-02
$3.89M
10-Q · filed 2018-08-02
$7.84M
derived: sum of 3 quarters · filed 2019-03-18
$11.34M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31$2.31M
10-Q · filed 2018-05-03
$6.27M
derived: sum of 2 quarters · filed 2019-03-18
$9.76M
derived: sum of 3 quarters · filed 2019-03-18
$11.74M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31$3.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$7.45M
derived: sum of 2 quarters · filed 2019-03-18
$9.42M
derived: sum of 3 quarters · filed 2019-03-18
$10.62M
10-K · filed 2019-03-18
2016-09-30$3.50M
10-Q · filed 2017-11-02
$5.47M
derived: sum of 2 quarters · filed 2017-11-02
$6.67M
10-Q · filed 2017-11-02
2016-06-30$1.98M
10-Q · filed 2017-08-09
$3.17M
10-Q · filed 2017-08-09
2016-03-31$1.19M
10-Q · filed 2017-05-03
2015-12-31$1.51M
10-K · filed 2018-02-28
2015-10-18$125.00K
10-Q · filed 2016-11-02
$147.00K
derived: sum of 2 quarters · filed 2016-11-02
$154.00K
10-Q · filed 2016-11-02
2015-07-24$22.00K
10-Q · filed 2016-08-05
$29.00K
10-Q · filed 2016-08-05
2015-04-24$7.00K
10-Q · filed 2016-05-09
$21.00K
10-K · filed 2018-02-28
2014-12-26$8.00K
10-K · filed 2018-02-28
2014-04-25$20.00K
10-K · filed 2017-03-01
2013-04-26$119.00K
10-KT · filed 2016-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Integer Holdings Corp (ITGR)United States$4.289B25.17
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53